Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Allman

Showing results (341-350 of 363) with videos related to

Pageof 37
Sort By:
The American Journal of Medicine|October 3, 2020
Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and HypertensionCharles Faselis, Phillip H Lam, Michael R Zile, et al.
The American Journal of Medicine|November 22, 2013
Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failureAli Ahmed, Robert C Bourge, Gregg C Fonarow, et al.
Journal of the American Medical Directors Association|May 15, 2017
Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart FailureHelen M Sheriff, Manik R Thogaripally, Gurusher Panjrath, et al.
The American Journal of Medicine|June 6, 2016
Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart FailureKumar Sanam, Vikas Bhatia, Navkaranbir S Bajaj, et al.
Circulation. Heart Failure|December 7, 2014
Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST)Linda G Jones, Mo-Kyung Sin, Fadi G Hage, et al.
The American Journal of Medicine|April 5, 2023
Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney DiseaseSamir Patel, Phillip H Lam, Evangelos I Kanonidis, et al.
The American Journal of Medicine|July 13, 2016
Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart FailureCherinne Arundel, Phillip H Lam, Rahul Khosla, et al.
JAMA Oncology|July 28, 2022
Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not RecommendedCharles Faselis, Joel A Nations, Charity J Morgan, et al.
The American Journal of Medicine|March 16, 2013
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failureRobert C Bourge, Jerome L Fleg, Gregg C Fonarow, et al.
The American Journal of Medicine|January 3, 2015
Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart FailureVikas Bhatia, Navkaranbir S Bajaj, Kumar Sanam, et al.
Pageof 37

Showing results (341-350 of 363) with videos related to

Sort By:
Pageof 37
The American Journal of Medicine|October 3, 2020
Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and HypertensionCharles Faselis, Phillip H Lam, Michael R Zile, et al.
The American Journal of Medicine|November 22, 2013
Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failureAli Ahmed, Robert C Bourge, Gregg C Fonarow, et al.
Journal of the American Medical Directors Association|May 15, 2017
Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart FailureHelen M Sheriff, Manik R Thogaripally, Gurusher Panjrath, et al.
The American Journal of Medicine|June 6, 2016
Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart FailureKumar Sanam, Vikas Bhatia, Navkaranbir S Bajaj, et al.
Circulation. Heart Failure|December 7, 2014
Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST)Linda G Jones, Mo-Kyung Sin, Fadi G Hage, et al.
The American Journal of Medicine|April 5, 2023
Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney DiseaseSamir Patel, Phillip H Lam, Evangelos I Kanonidis, et al.
The American Journal of Medicine|July 13, 2016
Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart FailureCherinne Arundel, Phillip H Lam, Rahul Khosla, et al.
JAMA Oncology|July 28, 2022
Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not RecommendedCharles Faselis, Joel A Nations, Charity J Morgan, et al.
The American Journal of Medicine|March 16, 2013
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failureRobert C Bourge, Jerome L Fleg, Gregg C Fonarow, et al.
The American Journal of Medicine|January 3, 2015
Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart FailureVikas Bhatia, Navkaranbir S Bajaj, Kumar Sanam, et al.
Pageof 37